Multivitamins High in Vitamin D Recalled

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida.

On World AIDS Day, CDC Urges HIV Prevention Pill

Dec. 1 is World AIDS Day. And this year's theme is "The Time to Act Is Now."

First Flu Vaccine with Adjuvant Approved

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant.

New Indication for Pradaxa

RIDGEFIELD, Conn., November 23, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Pradaxa® (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery.

FDA OKs Lung Cancer Rx Portrazza

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

A Breastfeeding Benefit — for Mom

Breastfeeding is known to provide a wide range of potential health benefits for babies. But what about for moms?

Progesterone: No Help for Recurrent Miscarriage

In the search for an effective treatment for recurrent miscarriage, one option appears to have fallen short.

Anthrax Vaccine Gets FDA Nod

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease.

Are Hep C Drugs Worth the Cost?

Newly developed drugs to treat hepatitis C infection can cost upward of $100,000 for a full course of treatment. Do the benefits of these drugs outweigh the costs?

Opdivo Approved to Treat Kidney Cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.